Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-22

Clinical Trial Update: Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of switching HIV-1 infected children from stavudine or zidovudine to tenofovir disoproxil fumarate; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RETROVIR (Zidovudine)
  • Viread (tenofovir disoproxil fumarate)
  • Zerit (stavudine)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2012-03-22